Stem Cell Transplant and Cellular Symposium 2024

Add to Calendar Stem Cell Transplant and Cellular Symposium 2024 5/11/2024 7:30:00 AM 5/11/2024 4:00:00 PM America/Chicago For More Details: https://vumc.cloud-cme.com/course/courseoverview?EID=94316 Description: The course will be offered on May 11, 2024 from 7:30 am to 4:00 pm at the Loews Vanderbilt Hotel, 2100 West End Avenue in Nashville. The course is designed to help primary care clinicians and community oncologists understand the potential of emerging applications of novel therapies in cellular therapy and bone marrow stem cell transplant for their patients with hematologic disorders and solid tumors. Af... Nashville, TN false MM/DD/YYYY


Saturday, May 11, 2024, 7:30 AM - 4:00 PM, Nashville, TN, Nashville, TN


Specialties - Medicine, Pathology, Microbiology and Immunology, Pediatrics, Pharmacy, Radiation Oncology


AMA PRA Category 1 Credits™ (5.75 hours), Non-Physician Attendance (5.75 hours)


The course will be offered on May 11, 2024 from 7:30 am to 4:00 pm at the Loews Vanderbilt Hotel, 2100 West End Avenue in Nashville. The course is designed to help primary care clinicians and community oncologists understand the potential of emerging applications of novel therapies in cellular therapy and bone marrow stem cell transplant for their patients with hematologic disorders and solid tumors. After listening to lectures and case discussions, primary care clinicians and community oncologists should be able to describe and discuss current stem therapy options for patients with hematological disorders or solid tumors, current CAR T-cell therapy indications, procedures, outcomes, and limitation


Objectives
After participating in this educational activity, you should be able to:

  1. 1. Describe current stem therapy options for patients with hematological disorders or solid tumors
  2. 2. Discuss current CAR T-cell therapy indications, procedures, outcomes, and limitations
  3. 3. Elaborate clinical strategies to coordinate management of patients starting and undergoing stem cell and cancer cell therapies


Vanderbilt University Medical Center is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Vanderbilt University Medical Center designates this live activity for a maximum 5.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.